Literature DB >> 19064199

Proton magnetic resonance spectroscopy in multiple sclerosis.

Balasrinivasa R Sajja1, Jerry S Wolinsky, Ponnada A Narayana.   

Abstract

Proton magnetic resonance spectroscopy ((1)H-MRS) provides tissue metabolic information in vivo. This article reviews the role of MRS-determined metabolic alterations in lesions, normal-appearing white matter, gray matter, and spinal cord in advancing our knowledge of pathologic changes in multiple sclerosis (MS). In addition, the role of MRS in objectively evaluating therapeutic efficacy is reviewed. This potential metabolic information makes MRS a unique tool to follow MS disease evolution, understand its pathogenesis, evaluate the disease severity, establish a prognosis, and objectively evaluate the efficacy of therapeutic interventions.

Entities:  

Mesh：

Year:  2009        PMID： 19064199      PMCID： PMC2615006          DOI： 10.1016/j.nic.2008.08.002

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN： 1052-5149            Impact factor:   2.264


  114 in total

1.  Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.

Authors:  P Sarchielli; O Presciutti; G P Pelliccioli; R Tarducci; G Gobbi; P Chiarini; A Alberti; F Vicinanza; V Gallai
Journal:  Brain       Date:  1999-03       Impact factor: 13.501

2.  MR spectroscopy of cervical spinal cord in patients with multiple sclerosis.

Authors:  Ayşe Tuba Karagülle Kendi; Funda Uysal Tan; Mustafa Kendi; Sevda Yilmaz; Sinef Huvaj; Serdar Tellioğlu
Journal:  Neuroradiology       Date:  2004-09       Impact factor: 2.804

3.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

Authors:  Jeroen J G Geurts; Lars Bö; Petra J W Pouwels; Jonas A Castelijns; Chris H Polman; Frederik Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

4.  Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain.

Authors:  S F Keevil; B Barbiroli; J C Brooks; E B Cady; R Canese; P Carlier; D J Collins; P Gilligan; G Gobbi; J Hennig; H Kügel; M O Leach; D Metzler; V Mlynárik; E Moser; M C Newbold; G S Payne; P Ring; J N Roberts; I J Rowland; T Thiel; I Tkác; S Topp; H J Wittsack; F Podo
Journal:  Magn Reson Imaging       Date:  1998-11       Impact factor: 2.546

5.  Hypointense and hyperintense lesions on magnetic resonance imaging in secondary-progressive MS patients.

Authors:  H P Adams; S Wagner; D F Sobel; L S Slivka; J C Sipe; J S Romine; E Beutler; J A Koziol
Journal:  Eur Neurol       Date:  1999-07       Impact factor: 1.710

6.  Multi-slice echo-planar spectroscopic MR imaging provides both global and local metabolite measures in multiple sclerosis.

Authors:  Henrik Kahr Mathiesen; Thomas Tscherning; Per Soelberg Sorensen; Henrik B W Larsson; Egill Rostrup; Olaf B Paulson; Lars G Hanson
Journal:  Magn Reson Med       Date:  2005-04       Impact factor: 4.668

7.  Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis.

Authors:  Marco Rovaris; Antonio Gallo; Andrea Falini; Beatrice Benedetti; Paolo Rossi; Mauro Comola; Giuseppe Scotti; Giancarlo Comi; Massimo Filippi
Journal:  Arch Neurol       Date:  2005-06

8.  Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.

Authors:  Juan He; Matilde Inglese; Belinda S Y Li; James S Babb; Robert I Grossman; Oded Gonen
Journal:  Radiology       Date:  2004-11-04       Impact factor: 11.105

9.  Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

Authors:  Radhika Srinivasan; Napapon Sailasuta; Ralph Hurd; Sarah Nelson; Daniel Pelletier
Journal:  Brain       Date:  2005-03-09       Impact factor: 13.501

10.  Total brain N-acetylaspartate concentration in normal, age-grouped females: quantitation with non-echo proton NMR spectroscopy.

Authors:  O Gonen; A K Viswanathan; I Catalaa; J Babb; J Udupa; R I Grossman
Journal:  Magn Reson Med       Date:  1998-11       Impact factor: 4.668
View more
  46 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

Authors:  Mike P Wattjes; Àlex Rovira; David Miller; Tarek A Yousry; Maria P Sormani; Maria P de Stefano; Mar Tintoré; Cristina Auger; Carmen Tur; Massimo Filippi; Maria A Rocca; Franz Fazekas; Ludwig Kappos; Chris Polman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

2.  Magnetic resonance monitoring of lesion evolution in multiple sclerosis.

Authors:  Alex Rovira; Cristina Auger; Juli Alonso
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

Review 3.  Neuroimaging in multiple sclerosis: neurotherapeutic implications.

Authors:  Nancy L Sicotte
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

Review 4.  The role of advanced magnetic resonance imaging techniques in primary progressive MS.

Authors:  Maria A Rocca; Martina Absinta; Massimo Filippi
Journal:  J Neurol       Date:  2011-08-04       Impact factor: 4.849

5.  Advanced magnetic resonance imaging techniques to better understand multiple sclerosis.

Authors:  Wafaa Zaaraoui; Bertrand Audoin; Jean Pelletier; Patrick J Cozzone; Jean-Philippe Ranjeva
Journal:  Biophys Rev       Date:  2010-04-02

6.  Improved spatial coverage for brain 3D PRESS MRSI by automatic placement of outer-volume suppression saturation bands.

Authors:  Eugene Ozhinsky; Daniel B Vigneron; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

Review 7.  Energy failure in multiple sclerosis and its investigation using MR techniques.

Authors:  David Paling; Xavier Golay; Claudia Wheeler-Kingshott; Raju Kapoor; David Miller
Journal:  J Neurol       Date:  2011-06-10       Impact factor: 4.849

8.  Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury.

Authors:  Ahmed Moghieb; Helen M Bramlett; Jyotirmoy H Das; Zhihui Yang; Tyler Selig; Richard A Yost; Michael S Wang; W Dalton Dietrich; Kevin K W Wang
Journal:  Mol Cell Proteomics       Date:  2016-05-05       Impact factor: 5.911

9.  Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia.

Authors:  L Fredrik Jarskog; Zhengchao Dong; Alayar Kangarlu; Tiziano Colibazzi; Ragy R Girgis; Lawrence S Kegeles; Deanna M Barch; Robert W Buchanan; John G Csernansky; Donald C Goff; Michael P Harms; Daniel C Javitt; Richard Se Keefe; Joseph P McEvoy; Robert P McMahon; Stephen R Marder; Bradley S Peterson; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2013-01-16       Impact factor: 7.853

10.  Neuronal and axonal degeneration in experimental spinal cord injury: in vivo proton magnetic resonance spectroscopy and histology.

Authors:  Junchao Qian; Juan J Herrera; Ponnada A Narayana
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.